Hemostatic and Tissue Sealing Agents Market

Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.

Hemostatic and Tissue Sealing Agents Market contains market size and forecasts of Hemostatic and Tissue Sealing Agents in global, including the following market information:

Global Hemostatic and Tissue Sealing Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hemostatic and Tissue Sealing Agents Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hemostatic and Tissue Sealing Agents companies in 2021 (%)

The global Hemostatic and Tissue Sealing Agents market was valued at 2882.9 million in 2021 and is projected to reach US$ 3514.7 million by 2028, at a CAGR of 2.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemostatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemostatic and Tissue Sealing Agents include J&J, Baxter, C R Bard, B Braun, Integra Life Sciences, Advance Medical Solution, CSL Behring, CryoLife and Zimmer Biomet, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hemostatic and Tissue Sealing Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemostatic and Tissue Sealing Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostatic and Tissue Sealing Agents Market Segment Percentages, by Type, 2021 (%)

Hemostatic

Sealant Gum

Global Hemostatic and Tissue Sealing Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostatic and Tissue Sealing Agents Market Segment Percentages, by Application, 2021 (%)

Minimally Invasive Surgery

General Surgery

Other

Global Hemostatic and Tissue Sealing Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostatic and Tissue Sealing Agents Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemostatic and Tissue Sealing Agents revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hemostatic and Tissue Sealing Agents revenues share in global market, 2021 (%)

Key companies Hemostatic and Tissue Sealing Agents sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Hemostatic and Tissue Sealing Agents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

J&J

Baxter

C R Bard

B Braun

Integra Life Sciences

Advance Medical Solution

CSL Behring

CryoLife

Zimmer Biomet

Pfizer

Medtronic

Smith & Nephew

Cohera Medical

Shanghai Haohai Biological Technology Co. Ltd.

Shandong Saikesaisi Biotechnology Co., Ltd

Chang ShaHai Run biological technology Co, LTD